Medicx Remains the Premier HIPAA-Compliant US Healthcare Marketing Technology & Analytics Company

0 126

Medicx Health, , announced the successful completion of its 2021 Risk Re-Identification Determination (RRID) Assessment, which is an evaluation of re-identification risks for Medicx’s patient audience data and use in targeted advertising. With more than a decade of experience in using the expert determination provision in the Federal HIPAA laws for its RRID assessments, Medicx remains the leader in its commitment to patient privacy.

Marketing Technology News: Appnovation’s Iain MacNeil Wins 2021 Report on Business Best Executive Award

Medicx remains committed to protecting patient privacy with this third-party risk assessment for patient audience data

The RRID assessment process harnesses the established expertise of de-identification privacy experts to assess the risk contained in Medicx’s de-identified data sets and application in targeted advertising. Assessments are performed and documented by third-party statisticians experienced in conducting HIPAA-related privacy analyses. Reviewers rely on the statistical de-identification provision of the law, in which a covered entity may determine that health information is not individually identifiable. This methodology is globally recognized and complies with accepted U.S. standards and guidelines, including The Health and Medicine Division (HMD) of the National Academies of Sciences and the Health Information Trust Alliance.

“This rigorous third-party assessment gives our clients strong confidence that we remove all HIPAA and privacy-related risks associated with reaching and communicating with their patient audiences, all while providing unmatched granularity and performance with those segments”, said Michael Weintraub, President & CEO of Medicx Health.

As privacy laws continue to evolve, Medicx remains committed to protecting patient privacy through this third-party risk assessment for patient audience data. This exacting review is performed annually, ensuring that Medicx audience data is de-identified properly, is defensible, and is compliant with all existing state and Federal laws.

Marketing Technology News: Accenture Acquires Strategy Activation Consultancy Root Inc. To Accelerate Organizational Culture…

Leave A Reply

Your email address will not be published.